Biologist

Zafrens Launches with $23M in Financing to Advance Multiple Stages of Drug Discovery in a Single Experiment at Unprecedented Scale

Retrieved on: 
Monday, December 11, 2023

The financing will be used to optimize breakthrough applications of the company’s Z-Screen™ platform and advance an internal pipeline.

Key Points: 
  • The financing will be used to optimize breakthrough applications of the company’s Z-Screen™ platform and advance an internal pipeline.
  • Complex cellular co-culture interactions can now be resolved at the molecular and functional levels simultaneously.
  • Large CRISPR, CAR-T, mRNA libraries, or endogenous molecular heterogeneity, can be mapped to their individual manifestations as cell behavior, cell-cell interactions and secretions.
  • Iterative drug discovery can now be replaced with exhaustive combinatorial profiling at extremely high resolution,” said Swamy Vijayan, CEO, Zafrens.

HOW VETERANS ARE TRANSITIONING FROM THE FRONT LINES TO BECOME BUSINESS OWNERS

Retrieved on: 
Tuesday, October 24, 2023

TYSONS, Va., Oct. 24, 2023 /PRNewswire/ --

Key Points: 
  • While almost 50% of veterans returning home from World War II started businesses, that number is down to 4.5% today.
  • The biggest challenge faced by today's veterans is access to the funds and social networks needed to start and grow their businesses.
  • That's why the PenFed Foundation launched the Veteran Entrepreneur Investment Program (VEIP), which equips military members and veterans with the resources and training needed to realize their business aspirations.
  • She's been named to the HillVets 100, an honor designated for the country's most influential veterans, service members and advocates.

Bridging the Science Gap: "Ask a Geneticist" connects public and educators with real scientists

Retrieved on: 
Wednesday, April 20, 2022

SAN JOSE, Calif., April 20, 2022 /PRNewswire/ -- The Tech Interactive relaunched one of the most popular tools for understanding genetics ahead of National DNA Day, April 25. Ask a Geneticist is a website powered by Stanford scientists answering questions from people curious about DNA. The wildly popular resource, which saw almost 4 million page views over the past year from all over the world, is now easier to navigate, read and explore burning questions like:

Key Points: 
  • Our hope is always to make genetics feel less daunting for people, especially teachers who need support with complicated topics," said Abbey Thompson, Director of Educational Outreach, Stanford Genetics.
  • "We're responding to the growing recognition that scientists need to learn how to communicate with the public, and the public needs greater access to factual information."
  • The Tech Interactive is a family-friendly science and technology center in the heart of downtown San Jose.
  • Our hands-on activities, experimental labs and design challenge experiences empower people to innovate with creativity, curiosity and compassion.

SeaWorld Returns 10 Critically Endangered Sea Turtles that Join the More than 2,500 Helped by the Rescue Team Since 1980

Retrieved on: 
Monday, March 7, 2022

These 10 join the more than 2,500 sick, stranded, and injured sea turtles rescued and rehabilitated by SeaWorld coast-to-coast since 1980.

Key Points: 
  • These 10 join the more than 2,500 sick, stranded, and injured sea turtles rescued and rehabilitated by SeaWorld coast-to-coast since 1980.
  • Earlier this Winter, SeaWorld San Antonio accepted 16 cold stunned turtles from the Sea Turtle Stranding and Salvage Network.
  • SeaWorld has rescued six of those seven species including Kemp's/Atlantic ridley (critically endangered), hawksbill (critically endangered), olive/Pacific ridley (vulnerable/threatened), leatherback (vulnerable/threatened), green (endangered), and the loggerhead (vulnerable/ threatened).
  • "Our Hawaii Park's efforts to rescue and incubate endangered species such as the Leatherback Sea Turtle is critical in the conservation of this valued species."

As Human Encounters With Grizzlies Climb, "One of Us: A Biologist's Walk Among Bears" Is The Book Every Outdoor Enthusiast Needs To Read

Retrieved on: 
Thursday, January 13, 2022

It also opens the door for more frequent interactions between grizzlies and humans, as the bears are increasingly forced to leave their depleted habitats in search of resources.

Key Points: 
  • It also opens the door for more frequent interactions between grizzlies and humans, as the bears are increasingly forced to leave their depleted habitats in search of resources.
  • Unfortunately, our misconceptions surrounding grizzlies often mean these interactions are charged with fear.
  • Barrie Gilbert graduated with a degree in biology from Queen's University and a PhD in zoology from Duke University.
  • "One of Us: A Biologist's Walk Among Bears" is available in print and e-book formats in most major online bookstores, including Amazon , Barnes & Noble , Google Play , and Friesen Press.

Slone Partners Places Sotirios Karathanasis as Chief Science Officer at Enveda Biosciences

Retrieved on: 
Thursday, April 29, 2021

b'SOUTH RIDING, Va., April 29, 2021 /PRNewswire-PRWeb/ -- Slone Partners , a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Sotirios Karathanasis, Ph.D. as the new Chief Science Officer (CSO) at Enveda Biosciences .

Key Points: 
  • b'SOUTH RIDING, Va., April 29, 2021 /PRNewswire-PRWeb/ -- Slone Partners , a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Sotirios Karathanasis, Ph.D. as the new Chief Science Officer (CSO) at Enveda Biosciences .
  • Over the course of his career, Karathanasis has led drug discovery teams with as many as 250 scientists across a wide scope of geographic locations, disciplines, and functional interfaces.
  • "His experience will help our team of biologists and medicinal chemists deliver validated, first-in-class drug candidates inspired by unique chemical starting points.
  • "\n"Having generated the largest dataset of medicinally-important plant metabolomes purpose-built for machine learning, Enveda is unlocking a new era of small molecule discovery," said Dr. Karathanasis.

Building Digitally Empowered Bioprocess Development Organizations to Accelerate Product Release, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, April 15, 2021

b'TORONTO, April 15, 2021 /PRNewswire-PRWeb/ --The global pandemic has put pressure on all areas of the drug discovery and development pipeline.

Key Points: 
  • b'TORONTO, April 15, 2021 /PRNewswire-PRWeb/ --The global pandemic has put pressure on all areas of the drug discovery and development pipeline.
  • "\nFor more information, or to register for this event, visit Building Digitally Empowered Bioprocess Development Organizations to Accelerate Product Release.\nBased in Boston, US and London,UK, Synthace is accelerating biological discovery & optimisation through computer-aided biology.
  • Our cloud software platform, Antha, empowers biologists by enabling them to flexibly program their lab automation without the need to code.
  • The graphical user interface has been designed by biologists for biologists, intuitively enabling them to automate their whole experiment from planning to execution, data collection and analysis.

The World's Most Influential Leaders in Biology and Earth Sciences Are at AcademicInfluence.com

Retrieved on: 
Wednesday, November 18, 2020

Thankfully, smart people in the fields of biology and earth sciences are working on solutions for these issues and exploring other challenges that affect life on this planet.

Key Points: 
  • Thankfully, smart people in the fields of biology and earth sciences are working on solutions for these issues and exploring other challenges that affect life on this planet.
  • Each list contains the 25 most influential scientists in the field over the past decade, along with honorable mentions who also have made outstanding contributions.
  • Not only does AcademicInfluence.com spotlight the biologists and earth scientists we all need to know, but it also interviews severalwith more interviews added regularlyincluding earth sciences luminaries such as Michael Mann and Jesse Ausubel and top biology influencers Adam Hart, Niles Eldredge, and Marcus Feldman.
  • "Connecting learners to leaders is what we're about," says Dr. Jed Macosko, academic director of AcademicInfluence.com and professor of physics at Wake Forest University.

In loving memory of Donald G. Comb, Founder of New England Biolabs®, Inc.

Retrieved on: 
Wednesday, October 7, 2020

IPSWICH, Mass., Oct. 7, 2020 /PRNewswire/ --It is with great sadness that we announce the passing of Donald G. Comb the founder of New England Biolabs, Inc. (NEB).

Key Points: 
  • IPSWICH, Mass., Oct. 7, 2020 /PRNewswire/ --It is with great sadness that we announce the passing of Donald G. Comb the founder of New England Biolabs, Inc. (NEB).
  • He was inspired by the beauty and diversity of marine organisms and, as a result, protecting biodiversity became an important priority.
  • After leaving a faculty position at Harvard, Don established New England Biolabs as a cooperative of scientists dedicated to providing research tools for molecular biologists.
  • NEW ENGLAND BIOLABS, and NEB are registered trademarks of New England Biolabs, Inc. LEEDis a registered trademark of U.S. Green Building Council, Co.

Insilico releases Pandomics, AI-powered platform for Novel Therapeutic Target Discovery

Retrieved on: 
Wednesday, September 23, 2020

HONG KONG, Sept. 23, 2020 /PRNewswire/ -- Insilico Medicine announces the official release of Pandomics - a part of the Pharma.ai AI platform designed to empower pharmaceutical target and drug discovery pipelines.

Key Points: 
  • HONG KONG, Sept. 23, 2020 /PRNewswire/ -- Insilico Medicine announces the official release of Pandomics - a part of the Pharma.ai AI platform designed to empower pharmaceutical target and drug discovery pipelines.
  • Insilico Medicine started working on an engine for target identification back in 2014.
  • "At Insilico, we have developed a platform that hands the power of bioinformatics over to the researcher's hands.
  • Biologists, clinicians and therapeutic target specialists, will gain a wide range of novel visual ways to interpret biological data.